网络生物安全:合成生物学中的DNA注入攻击
Cyberbiosecurity: DNA Injection Attack in Synthetic Biology
摘要:
今天,任意合成的DNA可以在网上订购,并在几天内交付。为了规范有意和无意产生的危险物质,大多数合成基因提供者筛选DNA订单。《合成双链DNA提供商筛选框架指南》中的一个弱点允许使用受早期恶意软件混淆技术启发的通用混淆程序来规避基于该指南的筛选协议。此外,合成基因工程工作流程的可访问性和自动化,加上网络安全控制不足,使得恶意软件能够干扰受害者实验室内的生物过程,从而关闭Ney等人在USENIX Security'17中提出的写入DNA分子的漏洞利用的可能性。在这里,我们提出了一个端到端的网络生物攻击,其中不知情的生物学家可能会被骗到他们的实验室内产生危险的物质。因此,尽管有常见的生物安全假设,攻击者不需要与生成的物质进行物理接触。攻击中最具挑战性的部分,即对模糊DNA的解码,是在活细胞内执行的,同时使用生物学家在体内基因编辑过程中常用的原始生物操作。这种攻击场景强调了加强合成DNA供应链以防范网络生物威胁的必要性。为了解决这些威胁,我们提出了一种改进的筛选方案,该方案考虑了体内基因编辑。
英文摘要:
Today arbitrary synthetic DNA can be ordered online and delivered within several days. In order to regulate both intentional and unintentional generation of dangerous substances, most synthetic gene providers screen DNA orders. A weakness in the Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA allows screening protocols based on this guidance to be circumvented using a generic obfuscation procedure inspired by early malware obfuscation techniques. Furthermore, accessibility and automation of the synthetic gene engineering workflow, combined with insufficient cybersecurity controls, allow malware to interfere with biological processes within the victim's lab, closing the loop with the possibility of an exploit written into a DNA molecule presented by Ney et al. in USENIX Security'17. Here we present an end-to-end cyberbiological attack, in which unwitting biologists may be tricked into generating dangerous substances within their labs. Consequently, despite common biosecurity assumptions, the attacker does not need to have physical contact with the generated substance. The most challenging part of the attack, decoding of the obfuscated DNA, is executed within living cells while using primitive biological operations commonly employed by biologists during in-vivo gene editing. This attack scenario underlines the need to harden the synthetic DNA supply chain with protections against cyberbiological threats. To address these threats we propose an improved screening protocol that takes into account in-vivo gene editing.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。